
|Articles|May 15, 2012
Reactions to the SGR Outside of the Physician Sector
The panel addresses various payment and delivery system changes in the long run that are more likely to be successful.
Advertisement
Advertisement
Advertisement
Advertisement
Trending on AJMC
1
Newer Agents, New Advantages: Brexpiprazole, Cariprazine, and Lumateperone in MDD
2
Dosing, Tolerability, and Formulary Impact: Aripiprazole and Quetiapine XR in MDD
3
60% of US Women Face Barriers to Postpartum, Mental Health Care
4
Counseling Vitiligo Patients on Time to Repigmentation
5
